We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.81%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$35.5B
AUM Growth
+$2.23B
(+6.7%)
Cap. Flow
+$7.5M
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
40.39%
Holding
665
New
57
Increased
234
Reduced
272
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$215M |
| 2 |
Accenture
ACN
|
+$184M |
| 3 |
Eli Lilly
LLY
|
+$169M |
| 4 |
UnitedHealth
UNH
|
+$159M |
| 5 |
Elevance Health
ELV
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$177M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$176M |
| 4 |
KLA
KLAC
|
+$118M |
| 5 |
Broadcom
AVGO
|
+$77.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.59% |
| 2 | Healthcare | 23.31% |
| 3 | Communication Services | 11.02% |
| 4 | Financials | 10.34% |
| 5 | Consumer Discretionary | 6.92% |
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2025 Portfolio in Review
As of Q3 2025, Grantham, Mayo, Van Otterloo & Co (GMO) held 665 positions worth $35.5B, up 6.7% from $33.2B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2025 filing shows 57 new, 234 increased, 272 reduced and 65 closed positions. Its largest new stake was Clean Harbors: 124,557 shares worth $28.9M. The largest sale was Oracle, an estimated $388M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Communication Services.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2025 buy was Clean Harbors: 124,557 shares worth $28.9M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Salesforce in Q3 2025, an estimated $215M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2025 reduction was Oracle, cutting an estimated $388M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited The AZEK Co in Q3 2025, selling an estimated $40.5M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $35.5B portfolio in Q3 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 57 new positions and closed 65 in Q3 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 6.7% quarter-over-quarter to $35.5B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2025, filed 13 Nov 2025.